ARCH Venture Partners IX, LLC - 10%+ Owner at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by ARCH Venture Partners IX, LLC since 7/8/2023

Holdings reported by ARCH Venture Partners IX, LLC for Lyell Immunopharma, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 18,206,358 $41.5 M $2.28 Jun 21, 2021 ARCH Venture Fund IX, L.P.
Common Stock 18,206,358 $41.5 M $2.28 Jun 21, 2021 ARCH Venture Fund IX Overage, L.P.
Series A Convertible Preferred Stock 0 Jun 21, 2021 ARCH Venture Fund IX, L.P. Common Stock
Series A Convertible Preferred Stock 0 Jun 21, 2021 ARCH Venture Fund IX Overage, L.P. Common Stock
series C Convertible Preferred Stock 0 Jun 21, 2021 ARCH Venture Fund IX, L.P. Common Stock
Series C Convertible Preferred Stock 0 Jun 21, 2021 ARCH Venture Fund IX Overage, L.P. Common Stock

Transactions reported by ARCH Venture Partners IX, LLC for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership